Patent details

EN | LT

LT - Adalimumabo veiksmingumo nustatymo būdai ankilozinį spondilitą turinčiuose subjektuose, naudojant CTX-II ir MMP3, kaip biomarkerius

EN - METHODS FOR DETERMINING EFFICACY OF ADALIMUMAB IN SUBJECTS HAVING ANKYLOSING SPONDYLITIS USING CTX-II AND MMP3 AS BIOMARKERS

Legal status

Patent lapsed (non-payment of fees)

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	G01N 33/68	(2006.01)

European patent
(11)	Number of the document	1948235
(13)	Kind of document	T
(96)	European patent application number	06849865.8
	Date of filing the European patent application	2006-10-31
(97)	Date of publication of the European application	2008-07-30
(45)	Date of publication and mention of the grant of the patent	2013-08-28
(46)	Date of publication of the claims translation	2013-11-25

PCT application
(86)	Number	PCT/US2006/042564
	Date	2006-10-31

PCT application publication
(87)	Number	WO 2007/089303
	Date	2007-08-09

Priority applications
(30)	Number	Date	Country code
	732444 P	2005-11-01	US

Inventors
(72)	MAKSYMOWYCH, Walter, P., CA WONG, Robert, L., US

Grantee
(73)	AbbVie Biotechnology Ltd, Clarendon House 2, Church Street, HM 11 Hamilton, BM

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Title
(54)	Adalimumabo veiksmingumo nustatymo būdai ankilozinį spondilitą turinčiuose subjektuose, naudojant CTX-II ir MMP3, kaip biomarkerius
	METHODS FOR DETERMINING EFFICACY OF ADALIMUMAB IN SUBJECTS HAVING ANKYLOSING SPONDYLITIS USING CTX-II AND MMP3 AS BIOMARKERS

Last renewal fee
	Payment date	Validity (years)	Amount
	2014-09-23	9	720.00 LTL

Legal status
	Patent lapsed (non-payment of fees)
	Invalidation date	2015-10-31